Menta Capital’s DexCom DXCM Stock Holding History

Menta Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-19,272	Closed	-$357K	–	671
2018 Q1	$357K	Sell	19,272 -47,232	-71%	-$698K	0.08%	427
2017 Q4	$954K	Buy	+66,504	New	+$864K	0.19%	201
2016 Q2	–	Sell	-40,000	Closed	-$679K	–	879
2016 Q1	$679K	Buy	+40,000	New	+$668K	0.09%	371
2014 Q2	–	Sell	-74,400	Closed	-$769K	–	537
2014 Q1	$769K	Buy	+74,400	New	+$769K	0.23%	122

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Menta Capital's DXCM Position: Q2 2018 in Review

Menta Capital sold out of DexCom (DXCM) in Q2 2018, closing a stake of 19,272 shares — an estimated $357K sold.

Menta Capital first reported a position in DXCM in Q1 2014 and held it in 4 quarters. The position peaked at $954K in Q4 2017. 290 funds tracked by Wall St. Rank hold DXCM as of Q2 2018.

Menta Capital reported no remaining DexCom position as of Q2 2018 after selling out during the quarter.
Menta Capital sold 19,272 DexCom shares in Q2 2018, an estimated $357K.
Menta Capital first reported a position in DexCom in Q1 2014 and held it in 4 quarters.
Menta Capital's DexCom position peaked at $954K in Q4 2017.
290 funds tracked by Wall St. Rank held DexCom as of Q2 2018.

Based on Menta Capital's 13F filing for Q2 2018, filed 14 Aug 2018.